Skip to main content

Advertisement

SpringerLink
Log in

Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The exact etiology and pathogenesis of chronic prostatitis (CP/CPPS) remain unclear. However, autoimmunity is a widely known theory. Precise treatment of CP/CPPS is not available. Here, we developed a new effective treatment method to prevent the occurrence of CP/CPPS. A total of 40 male C57BL/6 mice were randomly divided into four groups (n = 10): i.e., naive, model, high-dose (500 μg/ml), and low-dose (50 μg/ml) groups. High-dose and low-dose groups were orally given 0.4 ml of T2-containing soybean trypsin inhibitor (STI) at once after every 2 days for a total of 10 days. On day 10 and day 24 all the groups except naïve group were subcutaneously injected with 0.2 ml of T2 peptide along with CFA to make valid CP/CPPS models. Hematoxylin and eosin staining were used to evaluate the variation in CP/CPPS manifestation. Voiding behavior was recorded for the evaluation of urine frequencies. ELISA was used to measure the serum level of TNF-α in each group. The high- and low-dose groups of T2-containing STI displayed a reduction in urine frequencies, and inflammation, and there was a slight inflammatory infiltration as compared to the model group. In contrast, there was no difference observed in the TNF-α concentration of model as well as high- and low-dose groups compared to the naïve group. Our study demonstrates that oral T2-containing STI prevents CP/CPPS and provides an effective approach for the treatment of CP/CPPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Alexander, R.B., S. Ponniah, J. Hasday, and J.R. Hebel. 1998. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 52 (5): 744–749.

    Article  CAS  Google Scholar 

  2. Assoian, R.K., B.E. Fleurdelys, H.C. Stevenson, P.J. Miller, D.K. Madtes, E.W. Raines, R. Ross, and M.B. Sporn. 1987. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proceedings of the National Academy of Sciences of the United States of America 84 (17): 6020–6024.

    Article  CAS  Google Scholar 

  3. Bitar, D.M., and C.C. Whitacre. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cellular Immunology 112 (2): 364–370.

    Article  CAS  Google Scholar 

  4. Chen, H., L. Zhang, W.G. Hill, and W. Yu. 2017. Evaluating the Voiding Spot Assay in Mice: A Simple Method With Complex Environmental Interactions. American Journal of Physiology. Renal Physiology 313 (6): ajprenal.00318.02017.

    Article  Google Scholar 

  5. Cheng, Y., Y. Cao, A.U. Ihsan, F.U. Khan, X. Li, D. Xie, X. Cui, W. Wang, Z. Liu, C. Li, K.A. Ahmad, K.R. Sembatya, R. Mikrani, and X. Zhou. 2019. Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2. Inflammation 42 (3): 1071–1081. https://doi.org/10.1007/s10753-019-00968-5.

    Article  CAS  PubMed  Google Scholar 

  6. Cohen, J.M., A.P. Fagin, E. Hariton, J.R. Niska, M.W. Pierce, A. Kuriyama, J.S. Whelan, J.L. Jackson, and J.D. Dimitrakoff. 2012. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One 7 (8): e41941. https://doi.org/10.1371/journal.pone.0041941.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Collins, M.M., R.S. Stafford, M.P. O'Leary, and M.J. Barry. 1998. How common is prostatitis? A national survey of physician visits. Journal of Urology 159 (4): 1224–1228.

    Article  CAS  Google Scholar 

  8. Faria, A.M., and H.L. Weiner. 2006. Oral tolerance: therapeutic implications for autoimmune diseases. Clinical & Developmental Immunology 13 (2–4): 143–157.

    Article  CAS  Google Scholar 

  9. Higgins, P.J., and H.L. Weiner. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. Journal of Immunology 140 (2): 440–445.

    CAS  Google Scholar 

  10. Ihsan, A.U., F.U. Khan, W. Nawaz, M.Z. Khan, M. Yang, and X. Zhou. 2017. Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2. Biomedicine & Pharmacotherapy 91: 687–692. https://doi.org/10.1016/j.biopha.2017.05.004.

    Article  CAS  Google Scholar 

  11. John, H., A. Barghorn, G. Funke, T. Sulser, S. Hailemariam, D. Hauri, and H. Joller-Jemelka. 2001. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. European Urology 39 (1): 72–78.

    Article  CAS  Google Scholar 

  12. Khan, Farhan Ullah, Awais Ullah Ihsan, Waqas Nawaz, Muhammad Zahid Khan, Mengqi Yang, Gang Wang, Xiaoqian Liao, Lei Han, and Xiaohui Zhou. 2017. A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant. Immunology Letters 187: S0165247817301669.

    Article  Google Scholar 

  13. Kim, S.J., J.H. Kehrl, J. Burton, C.L. Tendler, K.T. Jeang, D. Danielpour, C. Thevenin, K.Y. Kim, M.B. Sporn, and A.B. Roberts. 1990. Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. Journal of Experimental Medicine 172 (1): 121–129.

    Article  CAS  Google Scholar 

  14. Krieger, J.N., L. Nyberg, and J.C. Nickel. 1999. NIH consensus definition and classification of prostatitis. JAMA 282 (3): 236–237.

    Article  CAS  Google Scholar 

  15. Li, Lequn, and Vassiliki A. Boussiotis. 2006. Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications. Journal of Molecular Medicine 84 (11): 887–899.

    Article  Google Scholar 

  16. Li, Meng, Jinhu Wu, and Yonggang Chen. 2012. Advances in animal models of prostatitis. Medical Review 18 (4): 567–570.

    CAS  Google Scholar 

  17. Lloyd, Mayer, and Ling Shao. 2004. Therapeutic potential of oral tolerance. Nature Reviews Immunology 4 (6): 407–419.

    Article  Google Scholar 

  18. Mahal, Brandon A., Jeffrey M. Cohen, Stephen A. Allsop, John B. Moore, Salman F. Bhai, Gino Inverso, and Jordan D. Dimitrakoff. 2011. The role of phenotyping in chronic prostatitis/chronic pelvic pain syndrome. Current Urology Reports 12 (4): 297–303.

    Article  Google Scholar 

  19. Maron, R., M. Guerau-de-Arellano, X. Zhang, and H.L. Weiner. 2001. Oral administration of insulin to neonates suppresses spontaneous and cyclophosphamide induced diabetes in the NOD mouse. Journal of Autoimmunity 16 (1): 21–28. https://doi.org/10.1006/jaut.2000.0471.

    Article  CAS  PubMed  Google Scholar 

  20. Miller, A., O. Lider, A.B. Roberts, M.B. Sporn, and H.L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proceedings of the National Academy of Sciences of the United States of America 89 (1): 421–425.

    Article  CAS  Google Scholar 

  21. Nagler-Anderson, C., L.A. Bober, M.E. Robinson, G.W. Siskind, and G.J. Thorbecke. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proceedings of the National Academy of Sciences of the United States of America 83 (19): 7443–7446. https://doi.org/10.1073/pnas.83.19.7443.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Nussenblatt, R.B., R.R. Caspi, R. Mahdi, C.C. Chan, F. Roberge, O. Lider, and H.L. Weiner. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. Journal of Immunology 144 (5): 1689–1695.

    CAS  Google Scholar 

  23. Pontari, Michel A., and Michael R. Ruggieri. 2008. Mechanisms in Prostatitis/Chronic Pelvic Pain Syndrome. Journal of Urology 179 (5): S61–S67.

    PubMed  Google Scholar 

  24. Rivero, Virginia E., Pablo Iribarren, and Clelia M. Riera. 1995. Mast Cells in Accessory Glands of Experimentally Induced Prostatitis in Male Wistar Rats. Clinical Immunology and Immunopathology 74 (3): 236–242.

    Article  CAS  Google Scholar 

  25. Schaeffer, Anthony J. 2008. Epidemiology and evaluation of chronic pelvic pain syndrome in men. J International journal of antimicrobial agents 31: 108–111.

    Article  Google Scholar 

  26. Sricharunrat, T., P. Pumirat, and P. Leaungwutiwong. 2018. Oral tolerance:Recent advances on mechanisms and potential applications. Asian Pacific Journal of Allergy and Immunology 36 (4): 207–216. https://doi.org/10.12932/ap0848.

    Article  PubMed  Google Scholar 

  27. Thompson, S.J., H.S. Thompson, N. Harper, M.J. Day, A.J. Coad, C.J. Elson, and N.A. Staines. 1993. Prevention of pristane-induced arthritis by the oral administration of type II collagen. Immunology 79 (1): 152–157.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Wang, Z.Y., J. Qiao, and H. Link. 1993. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. Journal of Neuroimmunology 44 (2): 209–214.

    Article  CAS  Google Scholar 

  29. Wu, Zaide, and Wu Yuhan. 2004. Surgery [M]. 6th ed, 683–684. Beijing: People’s Medical Publishing House.

    Google Scholar 

  30. Weiner, Howard L, Andre Pires da Cunha, Francisco Quintana, and Henry Wu. 2011. Oral tolerance. Immunological reviews 241 (1):241-259.

    Article  CAS  Google Scholar 

  31. Xiaofeng, Han. 2001. Progress in the mechanism and application of oral tolerance. International Journal of Immunology 24 (5): 265–268.

    Google Scholar 

  32. Xiaohui, Zhou, Han Lei, Zhou Zhiheng, Liu Zhongde, Yang Jixiang, Lu Yanwei, and You Chunlai. 2005. Morphological and molecular biological characteristics of a rat model of immune chronic nonbacterial prostatitis. Chinese Journal of Andrology: 290–295.

  33. Yanqun, A., Ye Zhangqun, and Sun Yinghao. 2014. Guidelines for the diagnosis and treatment of urological diseases in China. Beijing: People’s Health Publishing House.

    Google Scholar 

  34. Zhang, L., A.U. Ihsan, Y. Cao, Y. Cheng, and X. Zhou. 2017. Establishment of experimental autoimmune prostatitis model by T2 peptide in aluminium hydroxide adjuvant. Andrologia 50: 5.

    Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China [Grant Nos. 30973003 & 30901993] and Administration of TCM of Jiangsu province [Grant No. LZ11093].

Author information

Author notes

  1. Meng Tang and Rahat Ullah contributed equally to this work.

Authors and Affiliations

  1. Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China

    Meng Tang, Rahat Ullah, Junaid Wazir, Farhan Ullah Khan, Awais Ullah Ihsan, Xingxing Cui, Wenlu Wang, Min Hu, Yuqian Liu & Xiaohui Zhou

  2. Department of Surgery, Nanjing Shuiximen Hospital, Nanjing, 211198, Jiangsu Province, China

    Xiaohui Zhou

  3. Zhongda Hospital, Affiliated with Southeast University, Nanjing, 210017, Jiangsu Province, China

    Xiaohui Zhou

Authors
  1. Meng Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rahat Ullah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junaid Wazir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Farhan Ullah Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Awais Ullah Ihsan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xingxing Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wenlu Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Min Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuqian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiaohui Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Meng Tang, Rahat Ullah, and Junaid Wazir designed the study; Meng Tang and Rahat Ullah performed the experiments and wrote the manuscript; Xinxing Cui and Wenlu Wang contributed to the establishment of mice model. Min Hu and Yuqian Liu helped analyze the data; Farhan Ullah Khan and Awais Ullah Ihsan revised the manuscript; Xiaohui Zhou supervised the whole study.

Corresponding author

Correspondence to Xiaohui Zhou.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, M., Ullah, R., Wazir, J. et al. Effect of Oral T2 Antigen on Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Mice Model. Inflammation 42, 2086–2094 (2019). https://doi.org/10.1007/s10753-019-01072-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-019-01072-4

KEY WORDS

Search

Navigation